1. ADMET Assays on Tecan's LabCD-ADMET System
- Author
-
Howard Haspel, Theresa Towle, Lance Gleich, Shari Ommert, Michelle Shea, Hitesh Jindal, Bruce L. Carvalho, Noa Schmid, Praveen Bansal, Greg Kellogg, and Michael Contarino
- Subjects
Medical Laboratory Technology ,Engineering ,Chromatography ,business.industry ,Microfluidics ,Serum protein ,Pharmacology ,business ,Computer Science Applications ,ADME - Abstract
Screening for ADME/Tox properties of compounds is a key step in the drug development process. Three applications defining such properties, namely Cytochrome P450 Inhibition, Serum Protein Binding and P-glycoprotein Interaction were developed and the performance of each was evaluated on Tecan's LabCD-ADMET System. The LabCD-ADMET System is an automated platform which integrates microfluidics, in the form of the centrifugally driven LabCD device; liquid handling and assay robotics, in the form of a modified GENESIS liquid handling workstation; an incubation, spinner, and detection system, the ULTRA LabCD; and platform/application-specific software. The assay approach and the data for each application are presented. Two applications, Cytochrome P450 inhibition and serum protein binding assays, have also been externally validated at leading pharmaceutical companies within Tecan's Early Access Program (EAP). The LabCD-ADMET System provides a miniaturized, integrated, and automated turnkey solution for various ADME/Tox applications.
- Published
- 2003
- Full Text
- View/download PDF